Erik Amble
Director
Dentistry
Sonendo, Inc.
United States of America
Biography
Erik Amble has extensive venture capital investing experience, including the last 15 years in the healthare and life science industries. He is currently managing partner at NeoMed, an international venture capital company he founded. Mr. Amble previously co-founded and was chairman of the Norwegian Venture Capital Association. He has served as board member of Clavis Pharma AS, Genovision AS, Thommen Medical AG and Vessix Vascular Inc. He is currently a board member of Sequana Medical AG and JenaValve Inc. Mr. Amble earned a PhD in organic chemistry from the University of Oslo and a Master of Science degree in Management from the Graduate School of Business, Stanford University.
Research Interest
Nill.
